Oligodendroglioma

general

A rare, slow-growing tumor that begins in oligodendrocytes (cells that cover and protect nerve cells in the brain and spinal cord).

36

Centers

57

Active Trials

$6M

Cancer Funding

Specific Cancer Types(1)

Top Centers for Oligodendroglioma(36)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
79.3
2
High-Volume Research Center
71.8
3
NCI Comprehensive
Active Research Program
69.0
4
NCI Comprehensive
Active Research Program
66.8
5
NCI Comprehensive
Active Research Program
66.8
6
NCI Comprehensive
Active Research Program
66.8
7
NCI Clinical
Active Research Program
66.8
8
Active Research Program
66.8
9
Active Research Program
66.8
10
Active Research Program
66.8
11
NCI Comprehensive
Active Research Program
54.0
12
NCI Comprehensive
Active Research Program
52.4
13
NCI Comprehensive
Active Research Program
52.4
14
NCI Comprehensive
Active Research Program
52.4
15
NCI Comprehensive
Active Research Program
52.4
16
NCI Comprehensive
Active Research Program
52.4
17
NCI Comprehensive
Active Research Program
52.4
18
Active Research Program
52.4
19
NCI Comprehensive
Active Research Program
52.4
20
NCI Comprehensive
Active Research Program
52.4
21
Stephenson Cancer CenterOklahoma City, OK
NCI Clinical
Active Research Program
52.4
22
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
52.4
23
Active Research Program
52.4
24
Active Research Program
52.4
25
NCI Comprehensive
35.6
26
NCI Comprehensive
35.6
27
NCI Comprehensive
35.6
2835.6
2935.6
3035.6
31
NCI Comprehensive
35.6
32
NCI Comprehensive
35.6
33
NCI Comprehensive
35.6
3435.6
3535.6
3635.6

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →